12 May 2020 - Lung Foundation Australia is seeking input from consumers to inform submissions on proposed listings of respiratory medicines on the Pharmaceutical Benefits Scheme.
In July, the PBAC will consider 9 proposals (new listings, and changes to current listings) for lung cancer, chronic obstructive pulmonary disease, pulmonary arterial hypertension and influenza therapies.